Get Live Data

Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE
REMOVE ADS
REMOVE ADS

Latest Share Chat

  2. Share Prices
  3. Proteome Share Price
  4. Proteome Share Regulatory News
  5. Director's Dealing

Pin to quick picksProteome Regulatory News (PRM)

Proteome Information

Share Price Information for Proteome (PRM)

Share Price is delayed by 15 minutes
Get Live Data
1.50    0.00 (0.00%)
Bid:
1.50
Ask:
2.30
Spread: 0.80 (53.333%)
Market Cap: £5.26m
PRM Live PriceLast checked at - London Stock Exchange

Intraday Proteome Share Chart

Director's Dealing

25 Jul 2007 12:03

Proteome Sciences Plc ("Proteome Sciences" or "the Company")

DIRECTOR'S DEALING

Proteome Sciences announces that it has received notification today from James Malthouse, an Executive Director of the Company, that 50,000 ordinary shares that were held in his late wife's name have been transferred for a nil consideration to his adult daughter. As a consequence of this, the shares no longer form part of his beneficial holdings as defined by the AIM rules.

James Malthouse now has an interest in 250,000 Ordinary Shares of the issued ordinary share capital of the Company.

Enquiries Proteome Sciences plc

Christopher Pearce, Chief Executive Officer

Email: christopher.pearce@proteomics.com

James Malthouse, Finance Director

Email: james.malthouse@proteomics.com

Tel: +44 (0)1932 865065

Public Relations for Proteome Sciences

IKON AssociatesAdrian Shaw Tel: +44 (0)1483 535102Mobile: +44 (0)797 9900733Email: adrian@ikonassociates.com Coast CommunicationsMatt BaldwinTel: +44 (0) 1233 503200Mobile: +44 (0) 7930 439739

Email: matt@coastcommunications.com

PROTEOME SCIENCES PLC
12345678910
Date   Source Headline
4th Apr 20174:35 pmRNSPrice Monitoring Extension
4th Apr 20177:00 amRNSOption Awards
3rd Apr 20177:00 amRNSAppointment of Richard Dennis as CCO
31st Mar 20174:45 pmRNSBlock Admission Return
28th Mar 20177:00 amRNSPreliminary Results
9th Feb 20177:00 amRNSTrading Update & Notice of Results
4th Jan 20174:36 pmRNSHoldings in Company / PDMR Shareholding
3rd Jan 20171:34 pmRNSHoldings in Company / PDMR Shareholding
30th Dec 201611:42 amRNSHolding(s) in Company
19th Dec 20167:00 amRNSLaunch of new website
16th Dec 20169:28 amRNSHolding(s) in Company
29th Nov 201610:43 amRNSResult of GM and Completion of Placing
18th Nov 20169:46 amRNSHolding(s) in Company
8th Nov 201610:12 amRNSHolding(s) in Company
4th Nov 20163:52 pmRNSDirector/PDMR Shareholding & Total Voting Rights
2nd Nov 20164:35 pmRNSPrice Monitoring Extension
31st Oct 20167:00 amRNSPlacing and Subscription to raise £3.3 million
20th Oct 20164:40 pmRNSSecond Price Monitoring Extn
20th Oct 20164:35 pmRNSPrice Monitoring Extension
4th Oct 20164:35 pmRNSPrice Monitoring Extension
3rd Oct 20167:00 amRNSBlock Admission return
29th Sep 20167:00 amRNSHolding(s) in Company
22nd Sep 20167:00 amRNSPublication: Journal of Alzheimer's disease
15th Sep 20167:00 amRNSHalf-year Report
28th Jul 20167:00 amRNSTrading Update and Notice of Results
24th Jun 201612:30 pmRNSAGM Statement and Result of AGM
1st Jun 20167:00 amRNSAppointment of CEO
31st May 20163:20 pmRNSPublication of Annual Report
18th May 20167:01 amRNSCEO Appointment
18th May 20167:00 amRNSPreliminary Results
5th Apr 20167:00 amRNSDeep Protein Profiling Key re. Cancer Treatment
1st Apr 20168:04 amRNSBlock Admission return
29th Feb 20167:00 amRNSTrading Update
5th Jan 20169:43 amRNSDirector Dealing
14th Dec 20154:02 pmRNSDirector Dealing
14th Dec 20159:36 amRNSHolding(s) in Company
5th Nov 20157:00 amRNSClinical Trial Results for CK1d
1st Oct 20157:00 amRNSBlock Admission return
30th Sep 20157:00 amRNSUnaudited Interim Results
4th Sep 20157:00 amRNSChange of Adviser
17th Jul 201512:01 pmRNSAGM Statement
13th Jul 20152:48 pmRNSHolding(s) in Company
3rd Jul 20155:03 pmRNSHolding(s) in Company
23rd Jun 20157:05 amRNSPublication of Annual Report
23rd Jun 20157:00 amRNSPlacing to raise £2.5 million
29th May 20157:00 amRNSPreliminary results
30th Mar 20154:21 pmRNSBlocklisting Interim Review
9th Mar 20157:00 amRNSTrading Statement
1st Dec 20143:15 pmRNSDirectorate Change
28th Nov 20147:00 amRNSSysQuant - Update/Contract Awards
12345678910

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Recently viewed
DEC
Diversified Energy
LSE
3.00%
ORR
Oriole Resources
LSE
-4.93%
GATC
Gattaca
LSE
-2.36%
AFR
AFR.L
LSE
0.00%
MSLH
Marshalls
LSE
-1.13%
Trending
QHE
Quantum Helium
LSE
-1.67%
PREM
Premier African Minerals
LSE
7.50%
EZJ
easyJet
LSE
2.24%
AVCT
Avacta Group
LSE
0.28%
KEFI
Kefi Gold & Copper
LSE
-0.57%